MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The SYNAPSES study  (StudY to observe SafiNAmide in clinical Practice during the firSt post-commErcialization phaSe): methodology and results from the European feasibility survey

    G. Camattari, G. Abbruzzese, W. Jost, J. Kulisevsky, V. Tubazio, L. Simoni, The SYNAPSES investigators (Bresso, Italy)

    Objective: Here we present the design of a Drug Utilization Study of safinamide in the first post-commercialization phase and report results of the study feasibility…
  • 2017 International Congress

    Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

    R. Hoque (Dhaka, Bangladesh)

    Objective: To determine impact of Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh. Background: Patients with Parkinson’s disease are always at risk…
  • 2017 International Congress

    Analyses of physical activity on cognitive flexibility, depression and RBD in healthy elderly with high risk for neurodegenerative diseases

    S. Lerche, A. Gutfreund, K. Brockmann, I. Wurster, G. Eschweiler, F. Metzger, W. Maetzler, D. Berg (Tuebingen, Germany)

    Objective: In this study we set out to evaluate the effect of physical activity on cognition, fine motor movements and axial motor parameters in a…
  • 2017 International Congress

    Two ethnic clusters with Huntington’s disease in Israel – The case of Mountain Jews and Karaites

    J. Zitser, A. Thaler, N. Inbar, S. Naor, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To Assess frequencies of Huntington disease among different Israeli sub-populations Background: Worldwide prevalence estimates of Huntington's disease (HD) vary widely with no reliable information…
  • 2017 International Congress

    Tremor-Dominant Clinical Phenotype is Associated with Low Risk of Levodopa-Induced Dyskinesia in Parkinson’s Disease

    B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

    Objective:  To evaluate possible associations between epidemiological and clinical data with risk of levodopa-induced dyskinesias (LID) onset in  Parkinson’s disease (PD) patients. Background: LID are…
  • 2017 International Congress

    Occupational trichloroethylene exposure and Parkinson’s disease risk

    S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)

    Objective: To assess whether occupational exposure to the solvent trichloroethylene (TCE) is associated with increased risk of Parkinson's disease (PD). Background: Severe solvent intoxication can…
  • 2017 International Congress

    Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.

    E. Aluckal (Ernakulam, India)

    Objective: The objective of the present study was to evaluate the oral health-related quality of life among patients and their caregivers with Parkinson's disease. Background: Parkinson's disease can severely…
  • 2017 International Congress

    Demographic and Clinical Characters of Parkinson’s Disease in Tertiary Hospital in Kuwait

    W. Kamel, J. Al Hashel, S. Ahmed (Kuwait, Kuwait)

    Objective: To estimate the prevalence of Idiopathic Parkinson’s disease (PD) within patients attending a movement disorder clinic at tertiary hospital in Kuwait Background: PD is…
  • 2017 International Congress

    Calcium Channel Blocking Drugs and Risk of LRRK2 Parkinson’s Disease

    C. Marras, K. Marder, R. Alcalay, R. Saunders-Pullman, C. Meng, S. Goldman, A. Lang, M. Korell, M. San Luciano, E. Tolosa, B. Schuele, A. Brice, S. Goldwurm, G. Riboldazzi, C. Klein, G. Mellick, C. Sue, E.K. Tan, K. Brockmann, K. Hasegawa, S. Bressman, J. Ferreira, M. Tazir, W. Langston, D. Berg, C. Tanner (Toronto, ON, Canada)

    Objective: To test the association between Parkinson’s disease (PD) and calcium channel blocker CCB use in individuals carrying LRRK2 mutations. Background: LRRK2 mutation penetrance is…
  • 2017 International Congress

    Increased BMI May Protect Against Parkinson’s Disease: Evidence From A Mendelian Randomisation Study

    A. Noyce, D. Kia, G. Hemani, A. Nicolas, T. Price, E. Fernandez, P. Haycock, P. Lewis, T. Foltynie, G. Davey Smith, A. Schrag, A. Lees, J. Hardy, A. Singleton, M. Nalls, N. Pearce, D. Lawlor, N. Wood (London, United Kingdom)

    Objective: To use two-sample Mendelian randomisation (MR) to study the causal effect of body mass index (BMI) on Parkinson's disease (PD). Background: Both positive and…
  • « Previous Page
  • 1
  • …
  • 1374
  • 1375
  • 1376
  • 1377
  • 1378
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley